Healthcare of Ontario Pension Plan Trust Fund Reduces Stock Position in iShares Biotechnology ETF $IBB

Healthcare of Ontario Pension Plan Trust Fund lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 20.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 596,000 shares of the financial services provider’s stock after selling 154,000 shares during the period. Healthcare of Ontario Pension Plan Trust Fund owned about 1.23% of iShares Biotechnology ETF worth $100,587,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in IBB. Citigroup Inc. boosted its position in iShares Biotechnology ETF by 40.9% during the 4th quarter. Citigroup Inc. now owns 5,242,688 shares of the financial services provider’s stock valued at $884,808,000 after buying an additional 1,521,992 shares during the period. BNP Paribas Financial Markets lifted its position in shares of iShares Biotechnology ETF by 313.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,915,395 shares of the financial services provider’s stock worth $276,526,000 after purchasing an additional 1,451,820 shares during the period. WestEnd Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth about $106,276,000. Truist Financial Corp lifted its position in shares of iShares Biotechnology ETF by 2,239.6% in the 4th quarter. Truist Financial Corp now owns 642,023 shares of the financial services provider’s stock worth $108,354,000 after purchasing an additional 614,582 shares during the period. Finally, LPL Financial LLC lifted its position in shares of iShares Biotechnology ETF by 145.9% in the 4th quarter. LPL Financial LLC now owns 992,799 shares of the financial services provider’s stock worth $167,555,000 after purchasing an additional 589,033 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.1%

NASDAQ:IBB opened at $170.66 on Friday. The company has a 50-day moving average price of $170.28 and a 200-day moving average price of $170.65. iShares Biotechnology ETF has a 12 month low of $123.61 and a 12 month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were given a $0.1218 dividend. This represents a $0.49 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.